performed a similar randomized multicenter trial in 42 patients and found increased rate of adverse events in the TandemHeart group, but did not reach statistical significance [ 23 ].
← all excerpts
Complications from percutaneous-left ventricular assist devices versus intra-aortic balloon pump in acute myocardial infarction-cardiogenic shock.
1
—
—